Statistics in Medicine

Article	Citations
Joint modeling of association networks and longitudinal biomarkers: An application to childhood obesity	300
Bayesian response adaptive randomization design with a composite endpoint of mortality and morbidity	164
Issue Information	104
	46
Models for cluster randomized designs using ranked set sampling	45
Improving the Effectiveness of Sample Size Re‐Estimation: An Operating Characteristic Focused, Hybrid Frequentist‐Bayesian Approach	41
Issue Information	41
Nonparametric estimation of marked survival data in the presence of dependent censoring	41
Bayesian Borrowing With Multiple Heterogeneous Historical Studies Using Order Restricted Normalized Power Prior	40
Hierarchical Multi‐Label Classification With Gene‐Environment Interactions in Disease Modeling	35
Classification of disease recurrence using transition likelihoods with expectation‐maximization algorithm	33
Bayesian network mediation analysis with application to the brain functional connectome	33
Capturing the pool dilution effect in group testing regression: A Bayesian approach	31
Adaptive response‐dependent two‐phase designs: Some results on robustness and efficiency	31
Point estimation for adaptive trial designs I: A methodological review	30
	29
Issue Information	26
SIM 40th Anniversary	25
	25
Issue Information	24
Individualized empirical null estimation for exact tests of healthcare quality	23
Comparing and combining data from immune assays based on left‐censored multivariate normal model assuming common assay differences across settings	23
Approximate balancing weights for clustered observational study designs	23
Robust rank‐based meta‐analyses for two‐sample designs with application to platelet counts of malaria infection data	22
On the role of statisticians and modelers in responding to AIDS and COVID‐19	22

Issue Information	22
Overall assessment for selected markers from high‐throughput data	22
Real time monitoring and prediction of time to endpoint maturation in clinical trials	21
	21
Estimating Average Treatment Effects With Support Vector Machines	20
Issue Information	20
	19
Issue Information	19
Best practices in statistical computing	19
Issue Information	18
Issue Information	18
Flexible parametrization of graph‐theoretical features from individual‐specific networks for prediction	18
Likelihood ratio combination of multiple biomarkers via smoothing spline estimated densities	18
Enhancing long‐term survival prediction with two short‐term events: Landmarking with a flexible varying coefficient model	17
Modeling the multi‐state natural history of rare diseases with heterogeneous individual patient data: A simulation study	16
Evaluating effectiveness of public health intervention strategies for mitigating COVID‐19 pandemic	16
A Bayesian approach for estimating typhoid fever incidence from large‐scale facility‐based passive surveillance data	16
Training and capacity building in medical statistics in Sub‐Saharan Africa: Impact of the London School of Hygiene & Tropical Medicine MSc in Medical Statistics, 1969 to 2021	16
A novel approach to assess dynamic treatment regimes embedded in a SMART with an ordinal outcome	16
Estimands for factorial trials	16
Deep causal feature extraction and inference with neuroimaging genetic data	16
The scale transformed power prior for use with historical data from a different outcome model	15
Approximate Bayesian computation for the natural history of breast cancer, with application to data from a Milan cohort study	15
A semi‐parametric Bayesian model for semi‐continuous longitudinal data	15
Mixture of longitudinal factor analyzers and their application to the assessment of chronic pain	15
Selection of within‐run quality control rules for laboratory biomarkers	14
Sample size considerations for assessing treatment effect heterogeneity in randomized trials with heterogeneous intracluster correlations and variances	14
Discussion on “Is group testing ready for prime‐time in disease identification”	14
Issue Information	13
Constrained randomization and statistical inference for multi‐arm parallel cluster randomized controlled trials	13
Designing a longitudinal clinical trial based on a composite endpoint: Sample size, monitoring, and adaptation	13
Synthesizing studies for comparing different treatment sequences in clinical trials	13
Optimal planning of adaptive two‐stage designs	13
	12
Use of likelihood estimates for variances for the design and evaluation of multiregional clinical trials with heterogeneous variances	12
Penalized likelihood estimation of a mixture cure Cox model with partly interval censoring—An application to thin melanoma	12
Issue Information	12
Kernel density estimation in mixture models with known mixture proportions	12
CORRECTION	12
Issue Information	12
Issue Information	12
Similarity of competing risks models with constant intensities in an application to clinical healthcare pathways involving prostate cancer surgery	12
Nonparametric bounds in two‐sample summary‐data Mendelian randomization: Some cautionary tales for practice	11
Robust group variable screening based on maximum Lq‐likelihood estimation	11
	11
Sample size formula for a win ratio endpoint	11
When should matching be used in the design of cluster randomized trials?	11
Event‐specific win ratios for inference with terminal and non‐terminal events	11
A longitudinal transition imputation model for categorical data applied to a large registry dataset	11
A semiparametric Gumbel regression model for analyzing longitudinal data with non‐normal tails	11

Restricted sub‐tree learning to estimate an optimal dynamic treatment regime using observational data	10
	10
Handling parametric assumptions in principal causal effect estimation using Gaussian mixtures	10
Estimating adjusted risk differences by multiply‐imputing missing control binary potential outcomes following propensity score‐matching	10
Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trials	10
Statistical modeling of diabetic neuropathy: Exploring the dynamics of nerve mortality	10
Shared decision making of burdensome surveillance tests using personalized schedules and their burden and benefit	10
An extended Bayesian semi‐mechanistic dose‐finding design for phase I oncology trials using pharmacokinetic and pharmacodynamic information	10
Estimation of vaccine efficacy for variants that emerge after the placebo group is vaccinated	10
Unified estimation for Cox regression model with nonmonotone missing at random covariates	10
Prediction‐driven pooled testing methods: Application to HIV treatment monitoring in Rakai, Uganda	10
Combining Mendelian randomization with the sibling comparison design	10
Robust estimation and variable selection for the accelerated failure time model	10
Analyzing cohort studies with interval‐censored data: A new model‐based linear rank‐type test	10
Variable selection in semiparametric regression models for longitudinal data with informative observation times	10
Issue Information	10
Uncertainty in lung cancer stage for survival estimation via set‐valued classification	10
Point estimation, confidence intervals, and P‐values for optimal adaptive two‐stage designs with normal endpoints	10
G‐formula for observational studies under stratified interference, with application to bed net use on malaria	9
	9
Improving large‐scale estimation and inference for profiling health care providers	9
Inference about ratios of age‐standardized rates with sampling errors in the population denominators for estimating both rates	9
Modeling multiple correlated end‐organ disease trajectories: A tutorial for multistate and joint models with applications in diabetes complications	9
Issue Information	9
Double robust estimation of optimal partially adaptive treatment strategies: An application to breast cancer treatment using hormonal therapy	9
Issues with the expected information matrix of linear mixed models provided by popular statistical packages under missingness at random dropout	9
Issue Information	9
Estimation of standard deviations and inverse‐variance weights from an observed range	9
Estimation of non‐monotonic transition rates in a semi‐Markov process with covariates adjustments and application to caregivers' stress data	9
Sample size calculation in hierarchical 2×2 factorial trials with unequal cluster sizes	8
Maximum approximate likelihood estimation in accelerated failure time model for interval‐censored data	8
Clayton copula for survival data with dependent censoring: An application to a tuberculosis treatment adherence data	8
The spike‐and‐slab quantile LASSO for robust variable selection in cancer genomics studies	8
Optimal confidence intervals for the relative risk and odds ratio	8
A two‐level copula joint model for joint analysis of longitudinal and competing risks data	8
Bayesian federated inference for estimating statistical models based on non‐shared multicenter data sets	8
Issue Information	8
Network and covariate adjusted response‐adaptive design for binary response	8
Semiparametric estimation of restricted mean survival time as a function of restriction time	8
Practical implementation of the partial ordering continual reassessment method in a Phase I combination‐schedule dose‐finding trial	8
A flexible class of generalized joint frailty models for the analysis of survival endpoints	8
Comparing two hazard curves when there is a treatment time‐lag effect	8
An enhanced cross‐sectional HIV incidence estimator that incorporates prior HIV test results	8
Balancing versus modelling in weighted analysis of non‐randomised studies with survival outcomes: A simulation study	8
Issue Information	8
Selection of number of clusters and warping penalty in clustering functional electrocardiogram	8
Bayesian additive regression trees for multivariate skewed responses	8
	8
Bayesian mixture modelling with ranked set samples	8
Sensitivity analysis for principal ignorability violation in estimating complier and noncomplier average causal effects	8
Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs	7
Issue Information	7
Bayesian hierarchical profile regression for binary covariates	7
Letter to the editor: The use of fast approximate random forests using subsampling (rfsrc.fast) does not support the conclusion on sample sizes needed for random survival forests	7
Random Survival Forest for Censored Functional Data	7
Analysis of Longitudinal Lupus Data Using Multivariate t‐Linear Models	7
	7
Semiparametric regression analysis of clustered interval‐censored failure time data with a cured subgroup	7
Sample size adaptation designs and efficiency comparison with group sequential designs	7
Group sequential multi‐arm multi‐stage trial design with treatment selection	7
	7
A novel test by combining the maximum and minimum values among a large number of dependent Z‐scores with application to genome wide association study	7
Vaccine adverse event enrichment tests	7
	7
An approximate quasi‐likelihood approach for error‐prone failure time outcomes and exposures	7
Minimum sample size calculations for external validation of a clinical prediction model with a time‐to‐event outcome	7
Correction to “DL 101: Basic Introduction to Deep Learning With Its Application in Biomedical Related Fields”	7
Spatial modeling of epidermal nerve fiber patterns	7
	7
Assessing reproducibility of high‐throughput experiments in the case of missing data	7
	7
Bayesian record linkage with variables in one file	7
A simulation study of disaggregation regression for spatial disease mapping	7
	7
Unsupervised learning for medical data: A review of probabilistic factorization methods	7
	7
A ROC‐based test for evaluating the group difference with an application to neonatal audiology screening	7
Bayesian transformation models with partly interval‐censored data	7
	7
Sample size calculation for randomized selection trials with a time‐to‐event endpoint and a margin of practical equivalence	7

Semiparametric multivariate joint model for skewed‐longitudinal and survival data: A Bayesian approach	7
Laplacian‐P‐splines for Bayesian inference in the mixture cure model	7
Cluster randomized trial designs for modeling time‐varying intervention effects	7
Bayesian model‐averaged meta‐analysis in medicine	7
Meta‐analysis methods for multiple related markers: Applications to microbiome studies with the results on multiple α‐diversity indices	6
Multi‐state network meta‐analysis of progression and survival data	6
Inferring latent heterogeneity using many feature variables supervised by survival outcome	6
New late‐emphasis and combination tests based on infimum and supremum logrank statistics with application in oncology trials	6
Introduction to computational causal inference using reproducible Stata, R, and Python code: A tutorial	6
On the parameter estimation of Box‐Cox transformation cure model	6
Dose finding studies for therapies with late‐onset toxicities: A comparison study of designs	6
Exact inference for fixed effects meta‐analysis of 2×2$$ 2\times 2 $$ tables	6
Surveillance for endemic infectious disease outbreaks: Adaptive sampling using profile likelihood estimation	6
Point estimation for adaptive trial designs II: Practical considerations and guidance	6
A simplified stochastic EM algorithm for cure rate model with negative binomial competing risks: An application to breast cancer data	6
	6
Comparative poisson clinical trials of multiple experimental treatments vs a single control using the negative multinomial distribution	6
Multiparameter one‐sided tests for nonlinear mixed effects models with censored responses	6
Regression analysis of arbitrarily censored survival data under the proportional odds model	6
Robust approach for variable selection with high dimensional longitudinal data analysis	6
Tracking the transmission dynamics of COVID‐19 with a time‐varying coefficient state‐space model	6
Bayesian hierarchical models for high‐dimensional mediation analysis with coordinated selection of correlated mediators	6
	6
Functional Principal Component Analysis for Continuous Non‐Gaussian, Truncated, and Discrete Functional Data	6
Are the tests overpowered or underpowered? A unified solution to correctly specify type I errors in design of clinical trials for two sample proportions	6
	6
Noninferiority testing with censoring when the event rate is low	6
Quantifying the feasibility of shortening clinical trial duration using surrogate markers	6
Bayesian spatial models for voxel‐wise prostate cancer classification using multi‐parametric magnetic resonance imaging data	6
Categorisation of continuous covariates for stratified randomisation: How should we adjust?	6
Towards robust and accurate estimates of the incubation time distribution, with focus on upper tail probabilities and SARS‐CoV‐2 infection	6
Bayesian network meta‐regression hierarchical models using heavy‐tailed multivariate random effects with covariate‐dependent variances	6
	6
Use of win time for ordered composite endpoints in clinical trials	6
A Bayesian nonparametric approach to dynamic item‐response modeling: An application to the GUSTO cohort study	6
Investigation of patient‐sharing networks using a Bayesian network model selection approach for congruence class models	5
Prior elicitation for Gaussian spatial process: An application to TMS brain mapping	5
Sequential modeling for a class of reference‐based imputation methods in clinical trials with quantitative or binary outcomes	5
Confidence sets for a level set in linear regression	5
A puzzle of proportions: Two popular Bayesian tests can yield dramatically different conclusions	5
Transportability of model‐based estimands in evidence synthesis	5
RMST‐based multiple contrast tests in general factorial designs	5
Gene‐gene interaction analysis incorporating network information via a structured Bayesian approach	5
Testing a global null hypothesis using ensemble machine learning methods	5
Exact test and exact confidence interval for the Cox model	5
SpiderLearner: An ensemble approach to Gaussian graphical model estimation	5
A tutorial on individualized treatment effect prediction from randomized trials with a binary endpoint	5
Testing for an ignorable sampling bias under random double truncation	5
Estimands in heath technology assessment: a causal inference perspective	5
Improving main analysis by borrowing information from auxiliary data	5
Predictive generalized varying‐coefficient longitudinal model	5
Evaluating joint confidence region of hypervolume under ROC manifold and generalized Youden index	5
Dual‐agent dose‐finding in Phase I clinical trial—An extension of rapid enrollment design	5
Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time‐to‐event endpoints	5
Effective disease surveillance by using covariate information	5
Confidence interval estimation for treatment effects in cluster randomization trials based on ranks	5
A mixture distribution approach for assessing genetic impact from twin study	5
Bayesian analysis for partly linear Cox model with measurement error and time‐varying covariate effect	5
Reclaiming independence in spatial‐clustering datasets: A series of data‐driven spatial weights matrices	5
Bayesian workflow for disease transmission modeling in Stan	5
Effect modification in anchored indirect treatment comparison: Comments on “Matching‐adjusted indirect comparisons: Application to time‐to‐event data”	5
Two‐stage targeted maximum likelihood estimation for mixed aggregate and individual participant data analysis with an application to multidrug resistant tuberculosis	5
The polytomous discrimination index for prediction involving multistate processes under intermittent observation	5
Pitfalls of the concordance index for survival outcomes	5
A comparison of hyperparameter tuning procedures for clinical prediction models: A simulation study	5
A comparison of bias‐adjusted generalized estimating equations for sparse binary data in small‐sample longitudinal studies	5
Using instruments for selection to adjust for selection bias in Mendelian randomization	5
A Bayesian phase I/II platform design for co‐developing drug combination therapies for multiple indications	5
Do machine learning methods lead to similar individualized treatment rules? A comparison study on real data	5
An augmented illness‐death model for semi‐competing risks with clinically immediate terminal events	5
Comparison of treatments with ordinal responses in trials with sequential monitoring and response‐adaptive randomization	5
Comments on the debate between marginal and conditional estimands	5
Comparisons of statistical methods for handling attrition in a follow‐up visit with complex survey sampling	5
A simulation‐extrapolation approach for regression analysis of misclassified current status data with the additive hazards model	5
Robustness of κ‐type coefficients for clinical agreement	5
Fractional accumulative calibration‐free odds (f‐aCFO) design for delayed toxicity in phase I clinical trials	4
Modeling multivariate age‐related imaging variables with dependencies	4
Mediation analysis with multiple mediators under unmeasured mediator‐outcome confounding	4
	4
Kernel Cox partially linear regression: Building predictive models for cancer patients' survival	4
Issue Information	4
A new accuracy metric under three classes when subclasses are involved and its confidence interval estimation	4
Comments on “Sample size formula for a win ratio endpoint” by R. X. Yu and J. Ganju	4
Combined assessment of early and late‐phase outcomes in orphan drug development	4
How vague is vague? How informative is informative? Reference analysis for Bayesian meta‐analysis	4
Inferring medication adherence from time‐varying health measures	4
Issue Information	4
Studentized permutation method for comparing two restricted mean survival times with small sample from randomized trials	4
Estimation and visualization of heterogeneous treatment effects for multiple outcomes	4
Accounting for selection bias due to death in estimating the effect of wealth shock on cognition for the Health and Retirement Study	4
Quantile partially linear additive model for data with dropouts and an application to modeling cognitive decline	4
A shared‐parameter location‐scale mixed model to link the responsivity in self‐initiated event reports and the event‐contingent Ecological Momentary Assessments	4
Adjusted closed‐form confidence interval formulas for network meta‐analysis with a small number of studies	4
A Bayesian zero‐inflated beta‐binomial model for longitudinal data with group‐specific changepoints	4
A robust Bayesian bias‐adjusted random effects model for consideration of uncertainty about bias terms in evidence synthesis	4